Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKZF2 | Q9UKS7 | 11/20 | 0.46 |
| ▸ | IKZF1 | Q13422 | 5/20 | 0.44 |
| ▸ | PARP1 | P09874 | 2/20 | 0.39 |
| ▸ | DRD2 | P14416 | 3/20 | 0.38 |
| ▸ | DRD4 | P21917 | 3/20 | 0.38 |
| ▸ | DRD3 | P35462 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31278765 | 0.87 | PARP1 (0.51) | IKZF2IKZF1PARP1DRD2DRD4 | |
| SCHEMBL31279209 | 0.85 | DRD2 (0.41) | IKZF2IKZF1PARP1DRD2DRD4 | |
| SCHEMBL31278470 | 0.85 | IKZF2 (0.49) | IKZF2IKZF1PARP1DRD2DRD4 | |
| SCHEMBL31279073 | 0.85 | IKZF2 (0.49) | IKZF2IKZF1PARP1DRD2DRD4 | |
| SCHEMBL31279665 | 0.85 | IKZF2 (0.49) | IKZF2IKZF1PARP1DRD2DRD4 | |
| SCHEMBL31279763 | 0.83 | IKZF2 (0.46) | IKZF2IKZF1PARP1DRD2DRD4 | |
| SCHEMBL31279798 | 0.83 | IKZF2 (0.42) | IKZF2IKZF1PARP1DRD2DRD4 | |
| SCHEMBL31338317 | 0.83 | IKZF2 (0.68) | IKZF2IKZF1 | |
| SCHEMBL31278869 | 0.83 | IKZF2 (0.42) | IKZF2IKZF1PARP1DRD2DRD4 | |
| SCHEMBL31278994 | 0.83 | IKZF1 (0.49) | IKZF2IKZF1PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722207-A1 | OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| WO-2024245444-A1 | OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-12-05 | — | — | WO | claimed |
| EP-4722207-A1 | OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024245444-A1 | OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-12-05 | — | — | WO | disclosed |